173 related articles for article (PubMed ID: 28755163)
1. CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study.
Jiménez-Sousa MÁ; Gómez-Moreno AZ; Pineda-Tenor D; Medrano LM; Sánchez-Ruano JJ; Fernández-Rodríguez A; Artaza-Varasa T; Saura-Montalban J; Vázquez-Morón S; Ryan P; Resino S
Clin Transl Med; 2017 Dec; 6(1):26. PubMed ID: 28755163
[TBL] [Abstract][Full Text] [Related]
2. Single nucleotide polymorphisms of CXCL9-11 chemokines are associated with liver fibrosis in HIV/HCV-coinfected patients.
Pineda-Tenor D; Berenguer J; García-Álvarez M; Guzmán-Fulgencio M; Carrero A; Aldámiz-Echevarria T; Tejerina F; Diez C; Jiménez-Sousa MA; Fernández-Rodríguez A; Munoz-Fernandez MA; Resino S
J Acquir Immune Defic Syndr; 2015 Apr; 68(4):386-95. PubMed ID: 25559603
[TBL] [Abstract][Full Text] [Related]
3. CXCL9, CXCL10 and CXCL11 polymorphisms are associated with sustained virologic response in HIV/HCV-coinfected patients.
Pineda-Tenor D; Berenguer J; Jiménez-Sousa MA; Guzmán-Fulgencio M; Aldámiz-Echevarria T; Carrero A; García-Álvarez M; Diez C; Tejerina F; Briz V; Resino S
J Clin Virol; 2014 Nov; 61(3):423-9. PubMed ID: 25218243
[TBL] [Abstract][Full Text] [Related]
4. Study of CXCL9-11 gene polymorphisms in liver fibrosis among patients with chronic hepatitis C.
Magri MC; Alvarez MSM; Iogi AA; Alves GM; Manchiero C; Dantas BP; Prata TVG; Nunes AKDS; Tengan FM
Pathog Dis; 2021 Mar; 79(3):. PubMed ID: 33476381
[TBL] [Abstract][Full Text] [Related]
5. IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection.
Jiménez-Sousa MA; Berenguer J; Rallón N; Pineda-Tenor D; Aldamiz-Echevarria T; Soriano V; García-Álvarez M; Vazquez-Morón S; Restrepo C; Carrero A; Benito JM; Resino S
Liver Int; 2016 Sep; 36(9):1258-66. PubMed ID: 26836972
[TBL] [Abstract][Full Text] [Related]
6. The IL7RA rs6897932 polymorphism is associated with progression of liver fibrosis in patients with chronic hepatitis C: Repeated measurements design.
Jiménez-Sousa MÁ; Gómez-Moreno AZ; Pineda-Tenor D; Medrano LM; Sánchez-Ruano JJ; Fernández-Rodríguez A; Artaza-Varasa T; Saura-Montalbán J; Vázquez-Morón S; Ryan P; Resino S
PLoS One; 2018; 13(5):e0197115. PubMed ID: 29742149
[TBL] [Abstract][Full Text] [Related]
7. TRPM5 rs886277 Polymorphism Predicts Hepatic Fibrosis Progression in Non-Cirrhotic HCV-Infected Patients.
Resino S; Fernández-Rodríguez A; Pineda-Tenor D; Gómez-Moreno AZ; Sánchez-Ruano JJ; Artaza-Varasa T; Muñoz-Gómez MJ; Virseda-Berdices A; Martín-Vicente M; Martínez I; Jiménez-Sousa MA
J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33525598
[TBL] [Abstract][Full Text] [Related]
8. Optimal liver stiffness measurement values for the diagnosis of significant fibrosis and cirrhosis in chronic liver disease in Singapore.
Chang PE; Hartono JL; Ngai YL; Dan YY; Lim KB; Chow WC
Singapore Med J; 2019 Oct; 60(10):532-537. PubMed ID: 30556091
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants upstream of TNFAIP3 in the 6q23 region are associated with liver disease severity in HIV/HCV-coinfected patients: A cross-sectional study.
Jiménez-Sousa MA; Berenguer J; Fernández-Rodríguez A; Medrano LM; Aldámiz-Echevarria T; Pérez-Latorre L; Díez C; Martín-Vicente M; Gutiérrez-Rivas M; Martínez I; Resino S
Infect Genet Evol; 2019 Jan; 67():112-120. PubMed ID: 30336268
[TBL] [Abstract][Full Text] [Related]
10. Impact of
Jiménez-Sousa MÁ; Gómez-Moreno AZ; Pineda-Tenor D; Sánchez-Ruano JJ; Artaza-Varasa T; Martin-Vicente M; Fernández-Rodríguez A; Martínez I; Resino S
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 30970632
[No Abstract] [Full Text] [Related]
11. Association between CXCL9/10 polymorphisms and acute rejection of liver allograft.
Ostojic A; Markotic A; Kelava T; Mrzljak A
Medicine (Baltimore); 2019 Feb; 98(8):e14612. PubMed ID: 30813187
[TBL] [Abstract][Full Text] [Related]
12. The Myeloid-Epithelial-Reproductive Tyrosine Kinase (MERTK) rs4374383 Polymorphism Predicts Progression of Liver Fibrosis in Hepatitis C Virus-Infected Patients: A Longitudinal Study.
Jiménez-Sousa MÁ; Gómez-Moreno AZ; Pineda-Tenor D; Brochado-Kith O; Sánchez-Ruano JJ; Artaza-Varasa T; Gómez-Sanz A; Fernández-Rodríguez A; Resino S
J Clin Med; 2018 Nov; 7(12):. PubMed ID: 30477195
[TBL] [Abstract][Full Text] [Related]
13. Association between IL7R polymorphisms and severe liver disease in HIV/HCV coinfected patients: a cross-sectional study.
Guzmán-Fulgencio M; Berenguer J; Jiménez-Sousa MA; Pineda-Tenor D; Aldámiz-Echevarria T; García-Broncano P; Carrero A; García-Álvarez M; Tejerina F; Diez C; Vazquez-Morón S; Resino S
J Transl Med; 2015 Jun; 13():206. PubMed ID: 26123260
[TBL] [Abstract][Full Text] [Related]
14. Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.
Macías J; Mancebo M; Márquez M; Merino D; Téllez F; Rivero A; von Wichmann MA; López-Cortés LF; Merchante N; Santos J; Raffo M; Pérez-Pérez M; Camacho Á; Iribarren JA; Pineda JA
Hepatology; 2015 May; 61(5):1503-11. PubMed ID: 25545020
[TBL] [Abstract][Full Text] [Related]
15. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.
Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M
HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826
[TBL] [Abstract][Full Text] [Related]
16. Antiviral treatment significantly reduces the levels of CXCL9, CXCL10 and CXCL11 in chronic hepatitis C.
Radmanić L; Šimičić P; Bodulić K; Vince A; Zidovec-Lepej S
Cytokine; 2024 Apr; 176():156529. PubMed ID: 38335772
[TBL] [Abstract][Full Text] [Related]
17. Liver stiffness measurement among patients with chronic hepatitis B and C: results from a 5-year prospective study.
Christiansen KM; Mössner BK; Hansen JF; Jarnbjer EF; Pedersen C; Christensen PB
PLoS One; 2014; 9(11):e111912. PubMed ID: 25369038
[TBL] [Abstract][Full Text] [Related]
18. Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis.
Rinaldi L; Ascione A; Messina V; Rosato V; Valente G; Sangiovanni V; Zampino R; Marrone A; Fontanella L; de Rosa N; Orabona P; Buonomo C; Chirianni A; Adinolfi LE; Piai G
Infection; 2018 Apr; 46(2):231-238. PubMed ID: 29335905
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis.
Petta S; Cammà C; DI Marco V; Calvaruso V; Enea M; Bronte F; Butera G; Cabibi D; Craxì A
Aliment Pharmacol Ther; 2009 Sep; 30(6):603-13. PubMed ID: 19563503
[TBL] [Abstract][Full Text] [Related]
20. Liver stiffness measurement predicts liver-related events in patients with chronic hepatitis C: A retrospective study.
Gomez-Moreno AZ; Pineda-Tenor D; Jimenez-Sousa MA; Sánchez-Ruano JJ; Artaza-Varasa T; Saura-Montalban J; Ryan P; Resino S
PLoS One; 2017; 12(9):e0184404. PubMed ID: 28880930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
